News
The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, ...
Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...
The scientists significantly reduced nasal inflammation and improved the sense of smell in mice by using a vitamin D nasal spray, according to a study published in the journal International Forum of ...
I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla ...
Neurelis, Inc., today announced details of three poster presentations at the American Academy of Neurology (AAN) Annual ...
Treatment-Resistant Depression (TRD), a new option is available through Blessing’s Outpatient Behavioral Health ...
As mental health professionals increasingly adopt ketamine in clinical settings, understanding its benefits and risks is critical.
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an inspection of the facility that ...
13d
Techno-Science.net on MSNOxytocin: the love hormone or just a myth? 💕Oxytocin is often nicknamed the "love hormone" and frequently makes headlines in the press. But behind this idyllic image, ...
Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" under medical supervision and has a prescription from "an actual, real doctor." ...
Health Canada approves Hikma Pharma’s Kloxxado nasal spray 8 mg for treatment of known or suspected opioid overdose: London Monday, March 24, 2025, 13:00 Hrs [IST] Hikma Pharmac ...
The nasal spray had to go through many rounds of clinical testing, with some shown to improve depression, while others showed no improvement over a placebo. In 2019, the FDA approved Spravato for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results